Statins and colorectal cancer risk: A longitudinal study

Cancer Causes and Control

Volumn 24, Issue 4, 2013, Pages 777-782

  Clancy, Zoe ^a   Keith, Scott W ^b   Rabinowitz, Carol ^b   Ceccarelli, Matteo ^c   Gagne, Joshua J ^d   Maio, Vittorio ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Colorectal cancer; Pharmacoepidemiology; Statins

Indexed keywords

ANTIGLAUCOMA AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; ITALY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ITALY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84876462941     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-013-0160-x     Document Type: Article

References (30)

1. Kleinrock M (2011) The use of medicines in the united states: review of 2010. Retrieved from http://www.imshealth.com/deployedfiles/imshealth/Global/ Content/IMSInstitute/StaticFile/IHII-UseOfMed-report.pdf
2. Jasinska M, Owczarek J, Orszulak-Michalak D (2007) Statins: a new insight into their mechanisms of action and consequent pleiotropic effects. Pharmacol Rep 59:483-499
3. Boudreau DM, Yu O, Johnson J (2010) Statin use and cancer risk: a comprehensive review. Expert Opin Drug Saf 9(4):603-621
4. Hachem C, Morgan R, Johnson M, Kuebeler M, El-Serag H (2009) Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes. Am J Gastroenterol 104(5):1241-1248
5. Marelli C, Gunnarsson C, Ross S, Haas S, Stroup DF, Cload P, Clopton P, DeMaria AN (2011) Statins and risk of cancer: a retrospective cohort analysis of 45,857 matched pairs from an electronic medical records database of 11 million adult Americans. J Am Coll Cardiol 58:530-537
6. Peto R, Emberson J, Landray M, Baigent C, Collins R, Clare R, Califf R (2008) Analyses of cancer data from three ezetimibe trials. N Engl J Med 359:1357-1366
7. Newman TB, Hulley SB (1996) Carcinogenicity of lipid-lowering drugs. JAMA 275:55-60
8. Suh N, Reddy BS, DeCastro A, Paul S, Lee HJ, Smolarek AK, So JY, Simi B, Wang CX, Janakiram NB, Steele V, Rao CV (2011) Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats. Cancer Prev Res 4:1895-1902
9. Schreiber S, Nikolaus S, Hampe J (1998) Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42:477-484
10. Ray WA (2003) Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 158(9):915-920
11. Danaei G, Tavakkoli M, Hernan MA (2012) Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins. Am J Epidemiol 175(4):250-262
12. Friedman GD, Flick ED, Udaltsova N, Chan J, Quesenberry CP, Habel LA (2008) Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf 17(1):27-36
13. Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS, Low M, Greenson JK, Rennert G (2005) Statins and the risk of colorectal cancer. N Engl J Med 352(21):2184-2192
14. Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S (2007) Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation 115:27-33
15. Glynn RJ et al (2001) Paradoxical relations of drug treatment with morality in older persons. Epidemiology 12:682-689
16. Maio V, Yuen E, Rabinowitz C, Louis D, Jimbo M, Donatini A, Mall S, Taroni F (2005) Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy. J Health Serv Res Policy 10(4):232-238
17. Louis D, Yuen EJ, Maio V, Rabinowitz C, Robeson M, Smith K, Gonnella JS (2005) A population-based longitudinal healthcare database in the Emilia-Romagna Region, Italy: a resource for planning and research. Health Policy Newsl 2005:18
18. ACT/DDD Index WHO collaborating centre for drug statistics methodology. Available at http://www.whocc.no/atcddd/
19. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43(11):1130-1139
20. Schneeweiss S, Wang PS, Avorn J, Gynn RJ (2003) Improved comorbidity adjustment for predicting mortality in medicare populations. Health Serv Res 38(4):1103-1120
21. Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70(1):41-55
22. Cepdeda MS, Boston R, Farrar JT, Strom BL (2003) Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol 158:280-287
23. Rubin DB (2010) On the limitations of comparative effectiveness research. Stat Med 29:1991-1995
24. Bardou M, Barkun A, Martel M (2010) Effect of statin therapy on colorectal cancer. Gut 59:1572-1585
25. Johnson JR, Lacey JV, Lazovich D, Geller MA, Schairer C, Schatzkin A, Flood A (2009) Menopausal hormone therapy and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 18:196-203
26. Newcomb P, Pocobelli G, Chia V (2008) Why hormones protect against large bowel cancer? Adv Exp Biol 617:259-269
27. Schachter M (2005) Chemical, pharmacoeconomic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol 19(1):117-125
28. Coogan P, Rosenberg L, Strom B (2007) Statins and cancer. Epidemiology 18(4):520-521
29. Crocetti E, Buzzoni C, Zappa M (2010) Colorectal cancer incidence rates have decreased in central Italy. Eur J Cancer Prev 19:424-425
30. Yuen E, Louis D, Cisbani L, Rabinowitz C, De Palma R, Maio V, Leoni M, Grilli R (2011) Using administrative data to identify and stage breast cancer cases: implications for assessing quality of care. Tumori 97:428-435